- $3.31m
- -$2.05m
- $3.81m
- 43
- 59
- 19
- 35
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 12.8 | 15.3 | 7.74 | 5.48 | 3.81 |
Cost of Revenue | |||||
Gross Profit | 5.4 | 8.05 | 2.72 | 1.55 | 0.911 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 20.4 | 22.3 | 17.1 | 27.5 | 8.3 |
Operating Profit | -7.57 | -6.95 | -9.35 | -22 | -4.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.76 | -7.32 | -9.14 | -21.9 | -4.36 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.76 | -7.42 | -9.05 | -21.9 | -4.38 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.76 | -7.42 | -9.05 | -21.9 | -4.38 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.79 | -8.23 | -9.76 | -21.9 | -5.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -16.1 | -25.4 | -6.26 | -6.44 | -1 |